Three large drug distributors and a pharmaceutical company have reached a $260 opioid million with two Ohio counties, according to the New York Times.
The settlement avoided the first federal opioid trial that was slated to begin Monday. Drug distributors AmerisourceBergen, Cardinal Health, and McKesson, along with drug maker Teva Pharmaceutical Industries agreed to the settlement which is a combination of cash payouts and donations of addiction treatments.
The two-county settlement may become the framework for an agreement to settle thousands of similar cases brought against the pharmaceutical industry for the opioid epidemic that has killed hundreds of thousands of Americans.
Negotiations with the drug distributors and other companies for a global deal worth $48 billion in cash and donated addiction treatments were expected to resume Tuesday.